Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes

Citation
An. Varnavski et Aa. Khromykh, Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes, VIROLOGY, 255(2), 1999, pp. 366-375
Citations number
30
Categorie Soggetti
Microbiology
Journal title
VIROLOGY
ISSN journal
00426822 → ACNP
Volume
255
Issue
2
Year of publication
1999
Pages
366 - 375
Database
ISI
SICI code
0042-6822(19990315)255:2<366:NFRRSF>2.0.ZU;2-Q
Abstract
Noncytopathic replicons of the flavivirus Kunjin (KUN) were employed for ex pression and delivery of heterologous genes. Replicon vector C20DX2Arep, co ntaining a unique cloning site followed by the sequence of 2A autoprotease of foot-and-mouth disease virus, was constructed and used for expression of a number of heterologous genes including chloramphenicol acetyltransferase (CAT), green fluorescent protein (GFP), beta-galactosidase, glycoprotein G of vesicular stomatitis virus, and the Core and NS3 genes of hepatitis C v irus. The expression and proper processing of these genes upon transfection of BHK21. cells with the recombinant replicon RNAs were demonstrated by im munofluorescence, radioimmunoprecipitation, and appropriate reporter gene a ssays. Most of these recombinant KUN replicon RNAs were also successfully p ackaged into secreted virus-like particles (VLPs) by subsequent transfectio n with Semliki Forest virus replicon RNA expressing KUN structural genes. I nfection of BHK21 and Vero cells with these VLPs resulted in continuous rep lication of the recombinant replicon RNAs and prolonged expression of the c loned genes without any cytopathic effect. We also developed a replicon vec tor for generation of stable cell lines continuously expressing heterologou s genes by inserting an encephalomyelocarditis virus internal ribosomal ent ry site-neomycin transferase gene cassette into the 3'-untranslated region of the C20DX2Arep vector. Using this vector (C20DX2ArepNeo), stable BHK cel l lines persistently expressing GFP and CAT genes for up to 17 passages wer e established. Thus noncytopathic KUN replicon vectors with the ability to be packaged into VLPs should provide a useful tool for the development of n oninfectious and noncytopathic vaccines as well as for gene therapy applica tions. (C) Academic Press.